Immatics NV (IMTX)
6.80
-0.34
(-4.76%)
USD |
NASDAQ |
Oct 16, 13:27
Immatics SG&A Expense (TTM) : 63.90M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 63.90M |
| March 31, 2026 | 62.19M |
| December 31, 2025 | 57.91M |
| September 30, 2025 | 56.43M |
| June 30, 2025 | 53.88M |
| March 31, 2025 | 50.28M |
| December 31, 2024 | 50.22M |
| September 30, 2024 | 46.95M |
| June 30, 2024 | 44.36M |
| March 31, 2024 | 43.64M |
| December 31, 2023 | 41.29M |
| September 30, 2023 | 30.13M |
| June 30, 2023 | 20.47M |
| March 31, 2023 | 19.53M |
| December 31, 2022 | 19.65M |
| September 30, 2022 | 29.75M |
| Date | Value |
|---|---|
| June 30, 2022 | 39.50M |
| March 31, 2022 | 40.23M |
| December 31, 2021 | 39.97M |
| September 30, 2021 | 40.24M |
| June 30, 2021 | 41.27M |
| March 31, 2021 | 42.39M |
| December 31, 2020 | 39.05M |
| September 30, 2020 | 33.79M |
| June 30, 2020 | 26.10M |
| March 31, 2020 | 17.36M |
| December 31, 2019 | 13.13M |
| September 30, 2019 | 8.026M |
| June 30, 2019 | 4.947M |
| March 31, 2019 | 2.583M |
| December 31, 2018 | 0.00 |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| BioNTech SE | 833.57M |
| MediGene AG | -- |
| InflaRx NV | 16.14M |
| Twist Bioscience Corp. | 290.29M |
| Prime Medicine, Inc. | 54.39M |